Khichi Samrat S. 4

What Happened

• Samrat S. Khichi, Executive Vice President, Chief People Officer and General Counsel of CVS Health, was granted equity awards on 2026-03-31: 12,531 restricted stock units (RSUs) at $71.82/share valued at $899,976, and a derivative award of 80,838 shares (stock option grant) at $71.82/share with a reported value of $5,805,785.
• On 2026-04-01, Khichi surrendered 3,541 shares at $72.49/share (proceeds/value $256,687) to satisfy withholding taxes related to the RSU settlement. The awards are grants (not open-market purchases or sales).

Key Details

• Transaction dates and prices:
  • 2026-03-31: Award of 12,531 RSUs @ $71.82 (value $899,976).
  • 2026-03-31: Award of derivative/option covering 80,838 shares @ $71.82 (value $5,805,785).
  • 2026-04-01: 3,541 shares surrendered @ $72.49 to cover withholding taxes (value $256,687).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Notable footnotes:
  • RSUs awarded under the 2017 Incentive Compensation Plan; restrictions lapse in three equal installments beginning 3/31/2027.
  • The 3,541-share disposition was a share surrender to pay withholding taxes on RSU vesting/settlement (tax-withholding, code F).
  • The derivative award (options) becomes exercisable in three equal annual installments commencing 3/31/2027.
• Filing timeliness: Form 4 was filed 2026-04-02 for transactions dated 3/31–4/01 — appears timely based on standard Form 4 reporting windows.

Context

• These entries reflect equity awards and routine tax-withholding (surrendered shares), not open-market buying or selling for investment. The derivative entry is a grant of options that vest/exercise over future years; no immediate exercise-for-cash sale occurred.
• For retail investors: grants indicate compensation/retention awards rather than a direct insider purchase signal.